Clinical Trial Update: SIDAMI - Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (AMI) [Phase 4]

View source ↗

Summary

Phase 4 trial update of sildenafil (SIDAMI) for diastolic dysfunction after acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Jacob E Mueller | Conditions: Heart Failure, Diastolic | Phase 4 | Status: COMPLETED